Humanized anti-cd11b antibodies and methods of use thereof
AssigneeKaigene, Inc.
InventorsMinjae SHIN, Kyunghyun MIN, JongJoo LEE, Munkyung KIM, Suyeun HAN, Junho CHO
Life of this patent
Estimating the term…
Abstract
The present disclosure provides humanized anti-CD11b antibodies and methods of use thereof.
Claims28
A binding agent comprising a humanized antibody or antigen-binding fragment thereof that specifically binds to a polypeptide expressed by the human gene ITGAM.
4-8. (canceled)
(canceled)
(canceled)
(canceled)
22-24. (canceled)
The method of claim 2421, wherein the neurodegenerative disease is Alzheimer's disease, dementia, or spinal muscular atrophy.
(canceled)
The method of claim 2421, wherein the demyelinating disease is Chronic Inflammatory Demyelinating Polyneuropathy (“CIDP”) or Multifocal Motor Neuropathy (“MMN”).
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.